Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Recruitment Status: Completed"
topic_facet:"610"
topic_facet:"Medical Condition: Multiple Myeloma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
PubPharm (22)
1
A prospective, non-randomized clinical study for bortezomib, lenadomide/cyclophosphamide and dexamethasone in the treatment of primary multiple myeloma : A prospective, non-randomized clinical study for bortezomib and dexamethasone combined with lenadomide or cyclophosphamide in the treatment of primary multiple myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A prospective, non-randomized clinical study for bortezomib, lenadomide/cyclophosphamide and dexamethasone in the treatment of primary multiple myeloma : A prospective, non-randomized clinical study for bortezomib and dexamethasone combined with lenadomide or cyclophosphamide in the treatment of primary multiple myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (A.R.R.O.W) (ONO-7057-06) : A Randomized, Open-label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (ONO-7057-06)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (A.R.R.O.W) (ONO-7057-06) : A Randomized, Open-label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once-weekly versus Twice-weekly Carfilzomib Dosing (ONO-7057-06)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A randomized phase III study on the effect of Bortezomib combined with Adriamycin, Dexamethasone (AD) for induction treatment, followed by High Dose Melphalan and Bortezomib alone during maintenance in patients with multiple myeloma. : A randomized phase III study on the effect of Bortezomib combined with Adriamycin, Dexamethasone (AD) for induction treatment, followed by High Dose Melphalan and Bortezomib alone during maintenance in patients with multiple myeloma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A randomized phase III study on the effect of Bortezomib combined with Adriamycin, Dexamethasone (AD) for induction treatment, followed by High Dose Melphalan and Bortezomib alone during maintenance in patients with multiple myeloma. : A randomized phase III study on the effect of Bortezomib combined with Adriamycin, Dexamethasone (AD) for induction treatment, followed by High Dose Melphalan and Bortezomib alone during maintenance in patients with multiple myeloma.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell maturation antigen (BCMA), versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants with Relapsed and Lenalidomide-Refractory Multiple Myeloma CARTITUDE-4 : A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA, versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell maturation antigen (BCMA), versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants with Relapsed and Lenalidomide-Refractory Multiple Myeloma CARTITUDE-4 : A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA, versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (CANOVA) [M13-494] : A Phase3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11; 14) Positive Relapsed or Refractory Multiple Myeloma [M13-494]
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (CANOVA) [M13-494] : A Phase3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11; 14) Positive Relapsed or Refractory Multiple Myeloma [M13-494]
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Recruitment Status: Completed
Filter aufheben
Thema: 610
Filter aufheben
Thema: Medical Condition: Multiple Myeloma
Medienart
22
Aufsätze
22
E-Artikel
22
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
610
Medical Condition: Multiple Myeloma
Recruitment Status: Completed
20
Study Type: Interventional
2
Study Type: Observational
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
20
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
20
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...